Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MOH Stock Forecast 2025-2026
$152.06
Current Price
$7.87B
Market Cap
Buy 3
Hold 12
Sell 2
Wall St Analyst Ratings
Distance to MOH Price Targets
+51.9%
To High Target of $231.00
+13.8%
To Median Target of $173.00
-5.3%
To Low Target of $144.00
MOH Price Momentum
-0.7%
1 Week Change
-24.1%
1 Month Change
-53.9%
1 Year Change
-47.8%
Year-to-Date Change
-57.8%
From 52W High of $359.97
+4.8%
From 52W Low of $145.03
📊 TOP ANALYST CALLS
Did MOH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Molina Healthcare is one of their latest high-conviction picks.
Latest MOH Stock Price Targets & Analyst Predictions
Based on our analysis of 34 Wall Street analysts, MOH has a neutral consensus with a median price target of $173.00 (ranging from $144.00 to $231.00). The overall analyst rating is Buy (6.5/10). Currently trading at $152.06, the median forecast implies a 13.8% upside. This outlook is supported by 3 Buy, 12 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Stephen Baxter at Wells Fargo, projecting a 51.9% upside. Conversely, the most conservative target is provided by Andrew Mok at Barclays, suggesting a 5.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MOH Analyst Ratings
3
Buy
12
Hold
2
Sell
MOH Price Target Range
Low
$144.00
Average
$173.00
High
$231.00
Current: $152.06
Latest MOH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MOH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 24, 2025 | Barclays | Andrew Mok | Underweight | Downgrade | $144.00 |
| Oct 24, 2025 | Goldman Sachs | Scott Fidel | Neutral | Maintains | $167.00 |
| Oct 24, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $170.00 |
| Oct 24, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Maintains | $180.00 |
| Oct 14, 2025 | Goldman Sachs | Scott Fidel | Neutral | Initiates | $207.00 |
| Oct 14, 2025 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $204.00 |
| Oct 7, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $231.00 |
| Sep 5, 2025 | Bernstein | Lance Wilkes | Outperform | Maintains | $220.00 |
| Sep 4, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $185.00 |
| Aug 26, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $210.00 |
| Aug 15, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $198.00 |
| Jul 29, 2025 | JP Morgan | John Stansel | Neutral | Maintains | $184.00 |
| Jul 25, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $186.00 |
| Jul 25, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Downgrade | $210.00 |
| Jul 25, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $180.00 |
| Jul 25, 2025 | Truist Securities | David Macdonald | Hold | Downgrade | $180.00 |
| Jul 25, 2025 | Baird | Michael Ha | Neutral | Maintains | $179.00 |
| Jul 23, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $216.00 |
| Jul 16, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $335.00 |
| Jul 11, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $330.00 |
Molina Healthcare Inc. (MOH) Competitors
The following stocks are similar to Molina Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Molina Healthcare Inc. (MOH) Financial Data
Molina Healthcare Inc. has a market capitalization of $7.87B with a P/E ratio of 9.1x. The company generates $42.84B in trailing twelve-month revenue with a 2.1% profit margin.
Revenue growth is +11.6% quarter-over-quarter, while maintaining an operating margin of +1.2% and return on equity of +19.7%.
Valuation Metrics
Market Cap
$7.87B
Enterprise Value
$3.22B
P/E Ratio
9.1x
PEG Ratio
-1.2x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+11.6%
Gross Margin
+10.2%
Operating Margin
+1.2%
Net Margin
+2.1%
EPS Growth
-75.8%
Financial Health
Cash/Price Ratio
+108.1%
Current Ratio
1.7x
Debt/Equity
91.9x
ROE
+19.7%
ROA
+5.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Molina Healthcare Inc. (MOH) Business Model
About Molina Healthcare Inc.
What They Do
Provides managed care health plans for low-income individuals.
Business Model
Molina Healthcare generates revenue by offering health plans through government programs such as Medicaid and Medicare, focusing on low-income individuals and underserved populations. The company manages the complexities of state-run health programs and provides services like Medicaid management, Medicare Advantage plans, and Marketplace Exchange offerings.
Additional Information
Founded in 1980, Molina Healthcare has a strong commitment to enhancing access to healthcare in regions with limited medical resources. The company is recognized for its ability to navigate healthcare regulations and promote efficient resource allocation, contributing to public health policy and overall member well-being.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
18,000
CEO
Mr. Joseph Michael Zubretsky
Country
United States
IPO Year
2003
Website
www.molinahealthcare.comMolina Healthcare Inc. (MOH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Humana Beats Q3 Earnings on Premium Growth, Updates 2025 View
HUM tops Q3 earnings forecasts on strong premium growth, even as higher costs and lower memberships weigh on results.
Nov 05, 2025
By Zacks Equity Research
Analyst Blog
UnitedHealth's Q3 Beat Isn't Stopping the Bleed: Hold or Fold Now?
UNH's Q3 earnings beat couldn't stop a 9.6% stock slide as rising medical costs and margin strain test investor patience.
Nov 05, 2025
By Kaibalya Pravo Dey
Analyst Blog
Can Humana Beat Q3 Earnings Estimates on Growing Premiums?
HUM aims for a Q3 earnings beat as rising premiums and solid service revenues offset higher costs and lower income.
Nov 03, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Investors in Molina Healthcare (NYSE: MOH) have until December 2, 2025, to file a lead plaintiff motion in a class action for losses incurred between February 5 and July 23, 2025.
Why It Matters
The deadline for filing a lead plaintiff motion in Molina Healthcare's class action may impact stock volatility and investor sentiment, influencing future trading decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A class action lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) for alleged federal securities law violations affecting investors from February 5 to July 23, 2025.
Why It Matters
The class action lawsuit against Molina Healthcare may lead to financial liabilities, impacting stock performance and investor sentiment around the company's stability and governance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Investors in Molina Healthcare, Inc. (NYSE: MOH) have until December 2, 2025, to file lead plaintiff applications in a class action lawsuit for securities purchased between February 5 and July 23, 2025.
Why It Matters
The deadline for filing lead plaintiff applications in a class action lawsuit against Molina Healthcare could impact investor sentiment and stock performance, influencing trading decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A class action lawsuit has been filed against Molina Healthcare (NYSE: MOH) for securities violations. Investors who bought shares from Feb 5 to July 23, 2025, should contact Schall Law Firm by Dec 2, 2025.
Why It Matters
A class action lawsuit against Molina Healthcare could lead to financial liabilities and affect stock performance, signaling potential volatility for investors holding or considering the stock.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
A lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and its executives for potential federal securities law violations. Investors may seek more information at Bleichmar Fonti & Auld LLP's website.
Why It Matters
A lawsuit against Molina Healthcare could lead to financial penalties or reputational damage, affecting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Rosen Law Firm alerts Molina Healthcare (NYSE: MOH) investors that the lead plaintiff deadline for securities purchased between Feb 5 and July 23, 2025, is December 2, 2025.
Why It Matters
The deadline for lead plaintiffs in a securities class action against Molina Healthcare may impact stock price and investor sentiment, signaling potential legal risks or financial implications.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MOH Stock
What is Molina Healthcare Inc.'s (MOH) stock forecast for 2026?
Based on our analysis of 34 Wall Street analysts, Molina Healthcare Inc. (MOH) has a median price target of $173.00. The highest price target is $231.00 and the lowest is $144.00.
Is MOH stock a good investment in 2026?
According to current analyst ratings, MOH has 3 Buy ratings, 12 Hold ratings, and 2 Sell ratings. The stock is currently trading at $152.06. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MOH stock?
Wall Street analysts predict MOH stock could reach $173.00 in the next 12 months. This represents a 13.8% increase from the current price of $152.06. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Molina Healthcare Inc.'s business model?
Molina Healthcare generates revenue by offering health plans through government programs such as Medicaid and Medicare, focusing on low-income individuals and underserved populations. The company manages the complexities of state-run health programs and provides services like Medicaid management, Medicare Advantage plans, and Marketplace Exchange offerings.
What is the highest forecasted price for MOH Molina Healthcare Inc.?
The highest price target for MOH is $231.00 from Stephen Baxter at Wells Fargo, which represents a 51.9% increase from the current price of $152.06.
What is the lowest forecasted price for MOH Molina Healthcare Inc.?
The lowest price target for MOH is $144.00 from Andrew Mok at Barclays, which represents a -5.3% decrease from the current price of $152.06.
What is the overall MOH consensus from analysts for Molina Healthcare Inc.?
The overall analyst consensus for MOH is neutral. Out of 34 Wall Street analysts, 3 rate it as Buy, 12 as Hold, and 2 as Sell, with a median price target of $173.00.
How accurate are MOH stock price projections?
Stock price projections, including those for Molina Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 9, 2025 5:44 AM UTC